Humacyte Company

Humacyte is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale to improve the lives of patients and transform the practice of medicine.

Estimated Revenue: $10-50 Mn
Funding Status: Private investment in public equity(PIPE)
Headquarters: United States
Total Funding: $400 000 000
Last Funding Date: 17.02.2021
Investors Number: 9
Founded Date: 01.01.2004
Technology: Specific disorder-related
Industry: Longevity
Last Funding Type: Reverse Merger
Employee Number: 101-250